Cigna Corp (CI)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 5,269,000 | 5,513,000 | 8,397,000 | 6,790,000 | 10,868,000 |
| Revenue | US$ in thousands | 244,384,000 | 195,187,000 | 180,031,000 | 174,267,000 | 160,550,000 |
| Pretax margin | 2.16% | 2.82% | 4.66% | 3.90% | 6.77% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $5,269,000K ÷ $244,384,000K
= 2.16%
Cigna Corp's pretax margin has exhibited a declining trend over the past five years. Starting at 6.77% at the end of 2020, the pretax margin decreased to 3.90% by the end of 2021. Despite a slight improvement to 4.66% by the end of 2022, the trend reversed with a decline to 2.82% by the end of 2023. The downward trajectory continued as the pretax margin further decreased to 2.16% by the end of 2024. This declining trend warrants further investigation into the company's cost management, revenue generation, and overall operational efficiency.
Peer comparison
Dec 31, 2024
Company name
Symbol
Pretax margin
Cigna Corp
CI
2.16%
Centene Corp
CNC
2.61%
Elevance Health Inc
ELV
4.47%
Humana Inc
HUM
1.38%
Molina Healthcare Inc
MOH
3.91%
UnitedHealth Group Incorporated
UNH
5.01%